Company / SG&A Expense
DNA X, Inc. SG&A Expense History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$8.3M
FY2024
5-year range
$8.3M / $15.1M
FY2020-FY2024
Trend
-22.5%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A Expense has fluctuated over the past 6 years, ranging from $7M in FY2019 to $15M in FY2020.
Based on SEC 10-K filings.
$8M in FY2024 with a 5-year CAGR of +2.8%.
Improved from $10M to $8M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -5.6%
- 5-Year CAGR
- +2.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +2.8%, indicating consistent growth.
- In FY2024, sg&a expense decreased 22.5% year-over-year.
- Peak sg&a expense was recorded in FY2020.
- Lowest sg&a expense in the period was in FY2019.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $8.3M | -22.5% |
| FY2023 | $10.7M | +3.7% |
| FY2022 | $10.3M | +4.6% |
| FY2021 | $9.8M | -34.8% |
| FY2020 | $15.1M | +109.0% |
| FY2019 | $7.2M | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026